Assist. Prof. Dr. Alexander Kruglov | Biological Networks | Best Researcher Award
Head of Clinical Microbiology at Moscow Department of Health MMCC”Kommunarka”, Russia📖
Dr. Alexander N. Kruglov is a distinguished microbiologist with over 40 years of experience in clinical microbiology and infectious diseases. He has dedicated his career to advancing microbiological research, laboratory management, and the study of antimicrobial resistance. Dr. Kruglov has held key leadership roles in various prestigious medical institutions, contributing significantly to the understanding and management of infectious diseases. His expertise spans microbiological diagnostics, antimicrobial resistance surveillance, and clinical bacteriology.
Profile
Education Background🎓
Dr. Kruglov obtained his Doctor of General Medicine degree from Saratov State Medical Institute in 1981. He pursued postgraduate training in Microbiology and earned his Ph.D. from the All-Russian Research Institute of Applied Microbiology in 1984. Additionally, he has undergone specialized training in medical microbiology, bacteriology, and clinical trial methodologies at esteemed institutions such as the I.M. Sechenov Moscow Medical Academy and N.I. Pirogov Russian Scientific Research Medical University.
Professional Experience🌱
Currently serving as the Head of the Laboratory of Clinical Microbiology at the Moscow City Multidisciplinary Clinical Center “Kommunarka” since 2020, Dr. Kruglov has been instrumental in managing microbiological diagnostics in a high-complexity healthcare setting. Prior to this, he led clinical microbiology laboratories at City Hospital No. 24 and the National Agency of Clinical Pharmacology and Pharmacy. His career also includes extensive research roles at the All-Russian Research Institute of Applied Microbiology and the I.M. Sechenov Moscow Medical Academy. With over three decades of expertise in clinical microbiology, he has been at the forefront of infection control and antimicrobial resistance research.
Dr. Kruglov’s research primarily focuses on antimicrobial resistance mechanisms, clinical microbiology, and infectious disease epidemiology. He has contributed significantly to understanding carbapenem-resistant microorganisms, Candida auris population structures, and the impact of antifungal susceptibility on clinical outcomes. His work also includes studying risk factors associated with microbial colonization in intensive care units and exploring novel antimicrobial strategies against multidrug-resistant pathogens.
Author Metrics
Dr. Kruglov has co-authored several high-impact publications in peer-reviewed journals, covering topics such as carbapenem resistance, fungal infections, and antibiotic susceptibility. His recent works include studies published in the Journal of Epidemiology and Vaccinal Prevention, Journal of Fungi, and Russian Journal of Anesthesiology and Reanimatology. His research contributions have advanced clinical microbiology practices, providing valuable insights into microbial epidemiology and resistance patterns.
Awards & Honors
Dr. Kruglov has received multiple recognitions for his contributions to medical microbiology and infectious disease research. His work has been instrumental in shaping laboratory practices and infection control policies in healthcare settings. He continues to be a key figure in microbiological research, mentoring young scientists and leading critical investigations in clinical bacteriology.
1. Prevalence and Risk Factors for Colonization with Carbapenem-Resistant Microorganisms in Patients Admitted to a Multidisciplinary Hospital
- Journal: Epidemiology and Vaccinal Prevention
- Publication Date: January 14, 2025
- DOI: 10.31631/2073-3046-2024-23-6-83-103
- Contributors: O. G. Ni, B. Z. Belotserkovskiy, A. N. Kruglov, M. I. Matyash, A. O. Bykov, S. V. Yakovlev, E. M. Shifman, D. N. Protsenko
- Source: Crossref
2. Population Structure Based on Microsatellite Length Polymorphism, Antifungal Susceptibility Profile, and Enzymatic Activity of Candida auris Clinical Isolates in Russia
- Journal: Journal of Fungi
- Publication Date: January 4, 2025
- DOI: 10.3390/jof11010035
- Contributors: Ellina Oganesyan, Victoria Klimenteva, Irina Vybornova, Valentina Venchakova, Ekaterina Parshikova, Sergey Kovyrshin, Olga Orlova, Alexander Kruglov, Svetlana Gordeeva, Natalya Vasilyeva
- Source: Crossref
3. Risk Factors of Colonization and Diversity of Clinically Significant Carbapenemases in Gut Microbiota of ICU Patients: A Single-Center Prospective Observational Study
- Journal: Russian Journal of Anesthesiology and Reanimatology
- Publication Date: 2024
- DOI: 10.17116/anaesthesiology202405141
- Contributors: A.O. Bykov, E.M. Shifman, D.N. Protsenko, S.V. Yakovlev, B.Z. Belotserkovskiy, O.G. Ni, A.N. Kruglov, A.A. Bryleva, M.I. Matyash, E.S. Larin
- Source: Crossref
4. Comparative Activity of Lipoglycopeptide Antibiotics Against Gram-Positive Bacteria
- Journal: Antibiotics and Chemotherapy
- Publication Date: December 28, 2022
- DOI: 10.37489/0235-2990-2022-67-9-10-18-24
- Contributors: V. V. Gostev, O. S. Sulian, O. S. Kalinogorskaya, L. N. Popenko, A. N. Kruglov, S. A. Gordeeva, E. V. Nesterova, D. P. Gladin, N. N. Trophimova, P. S. Chulkova
- Source: Crossref
Conclusion
Dr. Alexander Kruglov is an excellent candidate for the Best Researcher Award in Biological Networks due to his outstanding contributions to clinical microbiology, antimicrobial resistance research, and infectious disease epidemiology. His extensive leadership, impactful publications, and dedication to microbiological advancements make him a top contender.
To further strengthen his impact, increased international collaboration, expansion into emerging fields, and greater public outreach could enhance his already distinguished career. Nonetheless, his research achievements and scientific leadership fully justify his nomination for this prestigious award.